Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

96 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Risk factors for development of Clostridium difficile infection due to BI/NAP1/027 strain: a meta-analysis.
Vardakas KZ, Konstantelias AA, Loizidis G, Rafailidis PI, Falagas ME. Vardakas KZ, et al. Int J Infect Dis. 2012 Nov;16(11):e768-73. doi: 10.1016/j.ijid.2012.07.010. Epub 2012 Aug 22. Int J Infect Dis. 2012. PMID: 22921930 Review.
Resistance to fosfomycin: Mechanisms, Frequency and Clinical Consequences.
Falagas ME, Athanasaki F, Voulgaris GL, Triarides NA, Vardakas KZ. Falagas ME, et al. Among authors: vardakas kz. Int J Antimicrob Agents. 2019 Jan;53(1):22-28. doi: 10.1016/j.ijantimicag.2018.09.013. Epub 2018 Sep 27. Int J Antimicrob Agents. 2019. PMID: 30268576 Review.
Resistance phenotypes and susceptibility of contemporary Serratia isolates in the university hospital of Crete, Greece.
Samonis G, Vardakas KZ, Maraki S, Stamouli P, Mavromanolaki VE, Kofteridis DP, Falagas ME. Samonis G, et al. Infect Dis (Lond). 2017 Nov-Dec;49(11-12):847-853. doi: 10.1080/23744235.2017.1361546. Epub 2017 Aug 2. Infect Dis (Lond). 2017. PMID: 28768448
In vitro susceptibility and resistance phenotypes in contemporary Citrobacter isolates in a University Hospital in Crete, Greece.
Maraki S, Vardakas KZ, Mavromanolaki VE, Kyriakidou M, Spais G, Kofteridis DP, Samonis G, Falagas ME. Maraki S, et al. Infect Dis (Lond). 2017 Jul;49(7):532-539. doi: 10.1080/23744235.2017.1297896. Epub 2017 Mar 9. Infect Dis (Lond). 2017. PMID: 28276281
The antibiotic pipeline for multi-drug resistant gram negative bacteria: what can we expect?
Falagas ME, Mavroudis AD, Vardakas KZ. Falagas ME, et al. Expert Rev Anti Infect Ther. 2016 Aug;14(8):747-63. doi: 10.1080/14787210.2016.1204911. Expert Rev Anti Infect Ther. 2016. PMID: 27400643 Review.
Susceptibility of contemporary isolates to fosfomycin: a systematic review of the literature.
Vardakas KZ, Legakis NJ, Triarides N, Falagas ME. Vardakas KZ, et al. Int J Antimicrob Agents. 2016 Apr;47(4):269-85. doi: 10.1016/j.ijantimicag.2016.02.001. Epub 2016 Feb 24. Int J Antimicrob Agents. 2016. PMID: 27013000 Review.
Fosfomycin.
Falagas ME, Vouloumanou EK, Samonis G, Vardakas KZ. Falagas ME, et al. Clin Microbiol Rev. 2016 Apr;29(2):321-47. doi: 10.1128/CMR.00068-15. Clin Microbiol Rev. 2016. PMID: 26960938 Free PMC article. Review.
Tetracyclines for multidrug-resistant Acinetobacter baumannii infections.
Falagas ME, Vardakas KZ, Kapaskelis A, Triarides NA, Roussos NS. Falagas ME, et al. Int J Antimicrob Agents. 2015 May;45(5):455-60. doi: 10.1016/j.ijantimicag.2014.12.031. Epub 2015 Feb 16. Int J Antimicrob Agents. 2015. PMID: 25801348 Review.
Effectiveness and safety of high-dose tigecycline-containing regimens for the treatment of severe bacterial infections.
Falagas ME, Vardakas KZ, Tsiveriotis KP, Triarides NA, Tansarli GS. Falagas ME, et al. Int J Antimicrob Agents. 2014 Jul;44(1):1-7. doi: 10.1016/j.ijantimicag.2014.01.006. Epub 2014 Feb 6. Int J Antimicrob Agents. 2014. PMID: 24602499 Review.
96 results
Jump to page
Feedback